About the Journal
The Ethan Cancer Research Journal (ECRJ) is an international, peer-reviewed, open-access journal committed to advancing knowledge in oncology and cancer biology. It provides a global platform for researchers, clinicians, and healthcare professionals to share original findings, innovative treatment strategies, and critical reviews aimed at reducing the global burden of cancer.
ECRJ publishes high-quality contributions that explore all aspects of cancer research, from molecular and cellular biology to clinical trials, diagnostics, and patient-centered care. The journal serves as a resource for fostering innovation, multidisciplinary collaboration, and the translation of research into improved cancer prevention and treatment outcomes.
Aim
The aim of the Ethan Cancer Research Journal is to promote impactful research that enhances understanding of cancer biology and accelerates progress in cancer prevention, diagnosis, and therapy. Specifically, the journal seeks to:
- Advance fundamental and translational cancer research across molecular, cellular, and clinical domains.
- Encourage innovation in diagnostics, therapeutics, immunotherapy, and personalized medicine.
- Foster international collaboration among cancer researchers, clinicians, and policy-makers.
- Support evidence-based approaches that improve patient survival rates, quality of life, and public health outcomes.
Scope
The scope of ECRJ encompasses a wide range of cancer-related disciplines, including but not limited to:
- Cancer Biology: Molecular mechanisms, tumor microenvironment, cancer genetics, and epigenetics.
- Oncology: Solid tumors, hematological malignancies, rare cancers, and clinical oncology research.
- Diagnostics and Imaging: Biomarkers, early detection methods, imaging technologies, and liquid biopsies.
- Treatment Strategies: Chemotherapy, radiotherapy, targeted therapies, immunotherapy, and precision medicine.
- Prevention and Public Health: Epidemiology, cancer prevention programs, risk factors, and lifestyle interventions.
- Translational and Clinical Research: Clinical trials, drug development, and bench-to-bedside approaches.
- Supportive and Palliative Care: Quality of life, pain management, survivorship, and psycho-oncology.
- Global Oncology: Disparities in cancer care, healthcare access, and strategies for low- and middle-income countries.
ECRJ welcomes original research articles, systematic reviews, meta-analyses, clinical trial reports, and case studies that advance the global fight against cancer.